| [1] |
Engin, A. The Definition and Prevalence of Obesity and Metabolic Syndrome[J]. Advences Expermental in Medicine and Biology, 2017, 960: 1-17.
|
| [2] |
Kelly T, Yang W, Chen CS, et al.Global burden of obesity in 2005 and projections to 2030[J]. International Journal of Obesity(2005), 2008, 32(9): 1431-7.
|
| [3] |
Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004[J]. Journal of the American College of Surgeons, 2008, 207(6): 928-34.
|
| [4] |
Bray GA, Frühbeck G, Ryan DH, et al. Management of obesity[J]. Lancet, 2016, 387(10031): 1947-1956.
|
| [5] |
Rothstein RI. Bariatric and Metabolic Endoscopy[J]. Gastrointestinal Endoscopy Clinics of North American, 2017, 27(2): xv-xvi.
|
| [6] |
Behary J, Kumbhari V. Advances in the Endoscopic Management of Obesity[J]. Gastroenterology Research and Practice, 2015, 2015: 757821.
|
| [7] |
Carvalho GL, Barros CB, Moraes CE, et al. The use of an improved intragastric balloon technique to reduce weight in pre-obese patients--preliminary results[J]. Obesity Surgery, 2011, 21(7): 924-927.
|
| [8] |
Brooks J, Srivastava ED, Mathus-Vliegen EM. One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K[J]. Obesity Surgery, 2014, 24(5): 813-819.
|
| [9] |
Ponce J, Woodman G, Swain J, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity[J]. Surgery Obesity Related Diseases, 2015, 11(4): 874-881.
|
| [10] |
Nobili V, Della Corte C, Liccardo D, et al. Obalon intragastric balloon in the treatment of paediatric obesity: a pilot study[J]. Pediatric Obesity, 2018, 13(4): 273.
|
| [11] |
Machytka E, Chuttani R, Bojkova M, et al. ElipseTM, a Procedureless Gastric Balloon for Weight Loss: a Proof-of-Concept Pilot Study[J]. Obesity Surgery, 2016, 26(3): 512-516.
|
| [12] |
Lopasso FP, Sakai P, Gazi BM, et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity[J]. Journal of Clinical Gastroenterology, 2008, 42(1): 48-53.
|
| [13] |
Marinos G, Eliades C, Raman Muthusamy V, et al. Weight loss and improved quality of life with a nonsurgical endoscopic treatment for obesity: clinical results from a 3- and 6-month study[J]. Surgery Obesity Related diseases:official journal of the American Society for Bariatric Surgery, 2014, 10(5): 929-34.
|
| [14] |
Sauer N, Rösch T, Pezold J, et al. A new endoscopically implantable device (SatiSphere) for treatment of obesity--efficacy, safety, and metabolic effects on glucose, insulin, and GLP-1 levels[J]. Obesity Surgery, 2013, 23(11): 1727-1733.
|
| [15] |
Neylan CJ, Dempsey DT, Tewksbury CM, et al. Endoscopic treatments of obesity: a comprehensive review[J]. Surgery Obesity Related diseases:official journal of the American Society for Bariatric Surgery, 2016, 12(5): 1108-1115.
|
| [16] |
Greenway FL, Aronne LJ, Raben A, et al. A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss[J]. Obesity (Silver Spring), 2019, 27(2): 205-216.
|
| [17] |
Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity[J]. Gastrointestinal Endoscopy, 2013, 78(3): 530-535.
|
| [18] |
López-Nava G, Bautista-Castaño I, Jimenez A,et al. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes[J].Surgery Obesity Related diseases:official journal of the American Society for Bariatric Surgery, 2015, 11(4): 861-865.
|
| [19] |
Klobucar Majanovic S, Brozovic B, Stimac D. Bariatric endoscopy: current state of the art, emerging technologies, and challenges[J]. Expert Review Medical Devices, 2017, 14(2): 149-159.
|
| [20] |
Brethauer SA, Chand B, Schauer PR, et al. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial.[J].Surgery Obesity Related diseases:official journal of the American Society for Bariatric Surgery, 2012, 8(3): 296-303.
|
| [21] |
Biertho L, Hould FS, Lebel S, et al. Transoral endoscopic restrictive implant system: a new endoscopic technique for the treatment of obesity[J].Surgery Obesity Related diseases:official journal of the American Society for Bariatric Surgery, 2010, 6(2): 203-205.
|
| [22] |
Verlaan T, Paulus GF, Mathus-Vliegen EM,et al. Endoscopic gastric volume reduction with a novel articulating plication device is safe and effective in the treatment of obesity (with video)[J]. Gastrointestinal Endoscopy, 2015, 81(2): 312-20.
|
| [23] |
Patel SR, Mason J, Hakim N. The Duodenal-Jejunal Bypass Sleeve (EndoBarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type II Diabetes[J]. The Indian Journal of Surgery, 2012, 74(4): 275-277.
|
| [24] |
Sandler BJ, Rumbaut R, Swain CP,et al. Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve[J]. Surgery Endoscopy, 2011, 25(9): 3028-3033.
|
| [25] |
Lee PC, Dixon J. Medical devices for the treatment of obesity[J]. Nature Reviews Gastroenterology Hepatology, 2017, 14(9): 553-564.
|
| [26] |
Nigam PK, Nigam A. Botulinum toxin[J]. Indian Journal Dermatology, 2010, 55(1): 8-14.
|
| [27] |
Sarr MG, Billington CJ, Brancatisano R, et al. The EMPOWER study: randomized, prospective, double-blind, multicenter trial of vagal blockade to induce weight loss in morbid obesity[J]. Obesity Surgery, 2012, 22(11): 1771-1782.
|
| [28] |
Sanmiguel CP, Conklin JL, Cunneen SA, et al. Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control[J]. Journal of Diabetes Science and Technology, 2009, 3(4): 964-970.
|
| [29] |
Sullivan S, Stein R, Jonnalagadda S, et al. Aspiration therapy leads to weight loss in obese subjects: a pilot study[J]. Gastroenterology, 2013, 145(6): 1245-1252.
|
| [30] |
Rajagopalan H, Cherrington AD, Thompson CC, et al. Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study[J]. Diabetes Care, 2016, 39(12): 2254-2261.
|
| [31] |
Spaulding L. Treatment of dilated gastrojejunostomy with sclerotherapy[J]. Obesity Surgery, 2003, 13(2): 254-257.
|
| [32] |
Abrams JA, Komanduri S, Shaheen NJ, et al. Radiofrequency ablation for the treatment of weight regain after Roux-en-Y gastric bypass surgery[J]. Gastrointestinal Endoscopy, 2018, 87(1): 275-279.
|